Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression. [electronic resource]
- The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry Sep 2009
- 744-51 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1545-7214
10.1097/JGP.0b013e3181ab8c61 doi
Adrenergic alpha-Antagonists--therapeutic use Aged Aged, 80 and over Aggression--drug effects Alzheimer Disease--diagnosis Behavioral Symptoms--drug therapy Brief Psychiatric Rating Scale Double-Blind Method Drug Administration Schedule Female Humans Male Neuropsychological Tests Pilot Projects Prazosin--therapeutic use Psychomotor Agitation--drug therapy Statistics, Nonparametric Treatment Outcome Washington